Cargando…
Hedgehog Signaling Inhibitors as Anti-Cancer Agents in Osteosarcoma
Osteosarcoma is a rare type of cancer associated with a poor clinical outcome. Even though the pathologic characteristics of OS are well established, much remains to be understood, particularly at the molecular signaling level. The molecular mechanisms of osteosarcoma progression and metastases have...
Autores principales: | Ram Kumar, Ram Mohan, Fuchs, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491684/ https://www.ncbi.nlm.nih.gov/pubmed/25985215 http://dx.doi.org/10.3390/cancers7020784 |
Ejemplares similares
-
Involvement and Clinical Aspects of MicroRNA in Osteosarcoma
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2016) -
Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma
por: Yao, Zhihong, et al.
Publicado: (2018) -
ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2014) -
Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line Systems
por: Muff, Roman, et al.
Publicado: (2012) -
Aberrant Hedgehog Signaling and Clinical Outcome in Osteosarcoma
por: Lo, Winnie W., et al.
Publicado: (2014)